Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nakase, Hiroshi | - |
dc.contributor.author | Keum, Bora | - |
dc.contributor.author | Ye, Byong Duk | - |
dc.contributor.author | Park, Soo Jung | - |
dc.contributor.author | Koo, Hoon Sup | - |
dc.contributor.author | Eun, Chang Soo | - |
dc.date.accessioned | 2021-12-22T02:56:12Z | - |
dc.date.available | 2021-12-22T02:56:12Z | - |
dc.date.created | 2021-08-30 | - |
dc.date.issued | 2016-07 | - |
dc.identifier.issn | 1598-9100 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/132476 | - |
dc.description.abstract | Background/Aims: Inflammatory bowel disease (IBD) management guidelines have been released from Western countries, but no adequate data on the application of these guidelines in Asian countries and no surveys on the treatment of IBD in real practice exist. Since there is a growing need for a customized consensus for IBD treatment in Asian countries, Asian Organization of Crohn's and Colitis performed a multinational survey of medical doctors who treat IBD patients in Asian countries. Methods: A questionnaire was developed between August 2013 and November 2013. It was composed of 4 domains: personal information, IBD diagnosis, IBD treatment, and quality of IBD care. Upon completion of the questionnaire, a web-based survey was conducted between 17 March 2014 and 12 May 2014. Results: In total, 353 medical doctors treating IBD from ten Asian countries responded to the survey. This survey data suggested a difference in available medical treatments (budesonide, tacrolimus) among Asian countries. Therapeutic strategies regarding refractory IBD (acute severe ulcerative colitis [UC] refractory to intravenous steroids and refractory Crohn's disease [CD]) and active UC were coincident, however, induction therapies for mild to moderate inflammatory small bowel CD are different among Asian countries. Conclusions: This survey demonstrated that current therapeutic approaches and clinical management of IBD vary among Asian countries. Based on these results and discussions, we hope that optimal management guidelines for Asian IBD patients will be developed. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN ASSOC STUDY INTESTINAL DISEASES | - |
dc.subject | ULCERATIVE-COLITIS | - |
dc.subject | CYTOMEGALOVIRUS-INFECTION | - |
dc.subject | THERAPY | - |
dc.subject | MANAGEMENT | - |
dc.subject | DIAGNOSIS | - |
dc.subject | AZATHIOPRINE | - |
dc.subject | MAINTENANCE | - |
dc.subject | INFLIXIMAB | - |
dc.subject | SMOKING | - |
dc.title | Treatment of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Keum, Bora | - |
dc.identifier.doi | 10.5217/ir.2016.14.3.231 | - |
dc.identifier.scopusid | 2-s2.0-85006049372 | - |
dc.identifier.wosid | 000405284800006 | - |
dc.identifier.bibliographicCitation | INTESTINAL RESEARCH, v.14, no.3, pp.231 - + | - |
dc.relation.isPartOf | INTESTINAL RESEARCH | - |
dc.citation.title | INTESTINAL RESEARCH | - |
dc.citation.volume | 14 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 231 | - |
dc.citation.endPage | + | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002129705 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | SMOKING | - |
dc.subject.keywordPlus | ULCERATIVE-COLITIS | - |
dc.subject.keywordPlus | CYTOMEGALOVIRUS-INFECTION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | AZATHIOPRINE | - |
dc.subject.keywordPlus | MAINTENANCE | - |
dc.subject.keywordPlus | INFLIXIMAB | - |
dc.subject.keywordAuthor | Asia | - |
dc.subject.keywordAuthor | Inflammatory bowel diseases | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | A web-survey | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.